financetom
financetom
/
Contact Us
Contact Us
Your name:
Your email address: * Required
Subject:
Message:
Related Articles >
UK Stocks-Factors to watch on July 20
UK Stocks-Factors to watch on July 20
Jul 19, 2026
July 20 (Reuters) - Britain's FTSE 100 index is seen opening lower on Monday, with futures down 0.1%. * YOUGOV ( YUGVF ): YouGov ( YUGVF ) is considering Wayne Levings, the former head of market research firm Kantar's operations, as one of the candidates to succeed co-founder and interim CEO Stephan Shakespeare, Sky News reported. * IP GROUP (...
Ryanair sees lower summer fares as profit misses forecasts
Ryanair sees lower summer fares as profit misses forecasts
Jul 19, 2026
DUBLIN, July 20 (Reuters) - Ryanair warned on Monday that its average summer fares looked set to be modestly down on last year amid uncertainty around the Iran war, while after-tax profit for the low-cost airline's April-June quarter fell short of analyst forecasts. Europe's largest airline by passenger numbers reported an after-tax profit of €538 million ($615.6 million) for its...
Analysis-Could AI chip boom make ASML Europe's first trillion-dollar firm?
Analysis-Could AI chip boom make ASML Europe's first trillion-dollar firm?
Jul 19, 2026
AMSTERDAM, July 20 (Reuters) - The global artificial intelligence boom has propelled ASML to the top of Europe's stock market, as soaring demand for AI computer chips flows to the Dutch company that dominates the market for the equipment needed to make them. After blowout second quarter earnings, investors and analysts are asking a once far-fetched question: could ASML become...
Novartis faces drug pipeline test with valuation premium in focus
Novartis faces drug pipeline test with valuation premium in focus
Jul 19, 2026
By Bhanvi Satija LONDON, July 20 (Reuters) - Novartis investors will look beyond Tuesday's quarterly results for indications about three major drug trial readouts due in the second half of the year seen as vital to justifying the Swiss drugmaker's premium valuation. Analysts say the experimental drugs - pelacarsen for cardiovascular disease, remibrutinib for multiple sclerosis and genetic disorder drug...
Copyright 2023-2026 - www.financetom.com All Rights Reserved